Cargando…
Health utilities and costs for neuromyelitis optica spectrum disorder
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare, neurological disease that places a significant burden on patients, their carers, and healthcare systems. OBJECTIVES: To estimate patient and carer health utilities and costs of NMOSD within the UK setting. METHODS: Patients with N...
Autores principales: | Hughes, Dyfrig A., Bourke, Siobhan, Jones, Angela, Bhatt, Rikesh, Huda, Saif, Mutch, Kerry, Jacob, Anu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991677/ https://www.ncbi.nlm.nih.gov/pubmed/35392962 http://dx.doi.org/10.1186/s13023-022-02310-z |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Development of a patient‐centred conceptual framework of health‐related quality of life in neuromyelitis optica: a qualitative study
por: Methley, Abigail M., et al.
Publicado: (2015) -
Neuromyelitis optica - an update: 2007–2009
por: Jacob, Anu
Publicado: (2009) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)